Category: Globe Newswire
Posted Date:
-
Bone Biologics Expands NB1 Trial Sites for Spine Fusion
BONE BIOLOGICS CORPORATION -
OWC Thunderbolt 5 Dock: Dual HDMI & 1.5m Cable Launch
Other World Computing (OWC) -
IPC Systems’ Emissions Targets Validated by SBTi
IPC Systems -
NeuroStar TMS EHR Integration: First-Ever System Connects TrakStar & AdvancedMD
Neuronetics; AdvancedMD -
Elmet Group Acquires German Tungsten Molybdenum Production
The Elmet Group -
BRE Commissions Rare Earth Pilot Plant, Secures Stage II Co-Funding
Brazilian Rare Earths -
GlobalFoundries Secures $375M for Quantum Tech R&D
GlobalFoundries Inc. -
Telos Xacta Enhances NARA Cyber Risk Management with AI
Telos Corporation -
Axel Merk Urges ASA Board: Offer Shareholder Liquidity Before BDC Conversion
Merk Investments LLC -
Zeo Energy Named Primary Storage Provider for Fulcrum Point Projects
Zeo Energy Corp. -
MAX Amphibious ATV on The Price Is Right for Star Trek Anniversary
Recreatives Industries, Inc. -
Confused.com Partners HUMAN Security for Digital Customer Journey Protection
HUMAN Security, Inc -
Aduro Presents Hydrochemolytic™ Polyolefin Recycling at CRE
Aduro Clean Technologies Inc. -
American EcoFuels Appoints New Directors to Drive SAF Growth
American EcoFuels Inc. -
MBX Biosciences Appoints Jeff Held Chief Legal Officer
MBX Biosciences, Inc. -
Eupraxia Pharmaceuticals Joins Nasdaq Global Select Market
Eupraxia Pharmaceuticals Inc. -
Avalyn Pharma to Present at Morgan Stanley Healthcare Conference
Avalyn Pharma Inc. -
PMV Pharma Prepares for Rezatapopt Launch with New CCO Appointment
PMV Pharmaceuticals, Inc. -
Longevity Health Holdings Secures Up to $625K Financing from Puritan Partners
Longevity Health Holding’s -
SimPure Countertop RO Water Filter: Back-to-School Sale for Students
Membrane Solutions Corp -
Simeon Kohl Appointed CEO & President of Health Catalyst
Health Catalyst, Inc. -
Phillips Edison Company to Present at BofA Global Real Estate Conference
Phillips Edison & Company, Inc. -
Lonvo-z FDA Priority Review for HAE | Intellia Therapeutics
Intellia Therapeutics, Inc. -
Flare Therapeutics Appoints New Board Member and CFO/CBO
Flare Therapeutics Inc. -
Hyperion DeFi Raises Guidance, Announces $20M Share Buyback
Hyperion DeFi, Inc. -
Spyre’s SPY003 Shows Positive Results in Ulcerative Colitis Trial
Spyre Therapeutics, Inc. -
Calidi Biotherapeutics to Present at H.C. Wainwright Global Investment Conference
Calidi Biotherapeutics, Inc -
Regeneron Lawsuit Deadline: Investors Can Lead Class Action – REGN
Robbins Geller Rudman & Dowd LLP -
Verrica Pharmaceuticals to Present at H.C. Wainwright Conference
Verrica Pharmaceuticals Inc. -
Phillips Edison to Speak at Barclays Retail REIT Panel
Phillips Edison & Company, Inc. -
FTC Solar Begins Fraser Coast Project Shipments in Australia
FTC Solar, Inc -
Lindus Therapeutics Appoints Dr. Gillian Cannon to Board
Lindus Therapeutics -
Rani Therapeutics to Participate in September Conferences
Rani Therapeutics, LLC -
Swvl Expands HSBC Facility to $1.4M, Adopts Global Payment Solutions
Swvl Holdings Corp -
AirNexis AN01 COPD Study Meets Primary Endpoint in China
AirNexis Therapeutics, Inc. -
Structure Therapeutics: Positive Oral Weight Loss Drug Clinical Data
Structure Therapeutics Inc. -
Dyne Therapeutics Presents DM1 Z-Basivarsen Clinical Data
Dyne Therapeutics, Inc. -
Avis Budget Group (CAR) Class Action Lawsuit – Investor Deadline
Robbins Geller Rudman & Dowd LLP -
Oportun Appoints Bill Franklin as Chief Financial Officer
Oportun Financial Corporation -
Dynamic Creatures Launches Interactive Character Robots for Hospitality & Entertainment
Dynamic Creatures Inc. -
3 E Network Unveils Full-Stack AI Storage Strategy
3E Network Technology Group Limited -
Desktop DePIN Node for Bitcoin Mining & AI Management
AGM Group Holdings Inc. -
Volatus Aerospace Qualifies for Canada’s Defence Drone Initiative
Volatus Aerospace Inc. -
Artiva Biotherapeutics: AlloNK Phase 3 RA Trial & 2026 Data Updates
Artiva Biotherapeutics, Inc. -
Nasus Pharma to Present at H.C. Wainwright Global Investment Conference
Nasus Pharma, Ltd. -
Pyxis Oncology Appoints Thomas Civik CEO & Chairman
Pyxis Oncology -
Euro Sun Mining Secures Financing for Rovina Valley Project
Euro Sun Mining Inc. -
New Flyer Secures Denver RTD Bus Order for BRT Project
NFI Group Inc -
Edible Garden Features Kick. Sports Nutrition & RTD at ECRM Event
Edible Garden AG Incorporated -
Cognition Therapeutics to Present at H.C. Wainwright Conference
Cognition Therapeutics, Inc. -
Bread Financial to Participate in Barclays Global Financial Services Conference
Bread Financial Payments, Inc. -
Medicus Pharma Focuses on Precision Oncology and CD228V
Medicus Pharma Ltd -
OptimizeRx to Speak at Lake Street Best Ideas Growth Conference
OptimizeRx Corporation -
ContentCon 2026: Build for Human & AI Audiences with Agentic AI
Contentstack Inc. -
ASML Begins Construction of New Eindhoven Campus
ASML Netherlands BV -
Generate Biomedicines to Present at September Investor Conferences
Generate Biomedicines, Inc. -
Rigetti Secures $100M US Funding for Quantum Computing R&D
Rigetti Computing, Inc. -
OKYO Pharma to Speak at Cantor Global Healthcare Conference
OKYO Pharma LTD -
Zenas BioPharma: Obexelimab IgG4-RD Investor Event on Sept 29
Zenas BioPharma -
Atea Pharmaceuticals to Present at Morgan Stanley Healthcare Conference
Atea Pharmaceuticals, Inc. -
American Fusion Expands IP to 130 Patent Applications & Provides Uplisting Update
American Fusion Inc. -
Phoenix Metals Accelerates Greenwood Drilling After Permit Update
Phoenix Metals Corp. -
NetraMark Appoints Finance Expert Kevin Felix as Strategic Advisor
NetraMark Holdings Inc. -
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Editas Medicine, Inc. -
Lahontan Gold Corp. Expands Technical & Business Team
Lahontan Gold -
G3 Goldfields Provides Update on Canadian Securities Exchange (CSE) Listing
G3 Goldfields Inc. -
Type 1 Diabetes Therapy: Sernova & Seraxis Merge to Form BetaNova
Sernova Biotherapeutics, Inc. -
Newron Secures EUR 5.5M Financing for Evenamide Phase 3 Program
Newron Pharmaceuticals SpA -
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics, Inc.